These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 8797573)
1. Reduced DNA repair capacity in lung cancer patients. Wei Q; Cheng L; Hong WK; Spitz MR Cancer Res; 1996 Sep; 56(18):4103-7. PubMed ID: 8797573 [TBL] [Abstract][Full Text] [Related]
2. Reduced DNA repair of benzo[a]pyrene diol epoxide-induced adducts and common XPD polymorphisms in breast cancer patients. Shi Q; Wang LE; Bondy ML; Brewster A; Singletary SE; Wei Q Carcinogenesis; 2004 Sep; 25(9):1695-700. PubMed ID: 15090466 [TBL] [Abstract][Full Text] [Related]
3. Reduced DNA repair capacity in head and neck cancer patients. Cheng L; Eicher SA; Guo Z; Hong WK; Spitz MR; Wei Q Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):465-8. PubMed ID: 9641488 [TBL] [Abstract][Full Text] [Related]
4. Sensitivity to DNA damage induced by benzo(a)pyrene diol epoxide and risk of lung cancer: a case-control analysis. Li D; Firozi PF; Wang LE; Bosken CH; Spitz MR; Hong WK; Wei Q Cancer Res; 2001 Feb; 61(4):1445-50. PubMed ID: 11245449 [TBL] [Abstract][Full Text] [Related]
5. In vitro induction of benzo(a)pyrene diol epoxide-DNA adducts in peripheral lymphocytes as a susceptibility marker for human lung cancer. Li D; Wang M; Cheng L; Spitz MR; Hittelman WN; Wei Q Cancer Res; 1996 Aug; 56(16):3638-41. PubMed ID: 8705998 [TBL] [Abstract][Full Text] [Related]
6. Benzo(a)pyrene diol epoxide-induced chromosomal aberrations and risk of lung cancer. Wei Q; Gu J; Cheng L; Bondy ML; Jiang H; Hong WK; Spitz MR Cancer Res; 1996 Sep; 56(17):3975-9. PubMed ID: 8752166 [TBL] [Abstract][Full Text] [Related]
7. Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Spitz MR; Wu X; Wang Y; Wang LE; Shete S; Amos CI; Guo Z; Lei L; Mohrenweiser H; Wei Q Cancer Res; 2001 Feb; 61(4):1354-7. PubMed ID: 11245433 [TBL] [Abstract][Full Text] [Related]
8. A modified host-cell reactivation assay to measure repair of alkylating DNA damage for assessing risk of lung adenocarcinoma. Wang L; Wei Q; Shi Q; Guo Z; Qiao Y; Spitz MR Carcinogenesis; 2007 Jul; 28(7):1430-6. PubMed ID: 17341660 [TBL] [Abstract][Full Text] [Related]
9. Factors that influence the DNA repair capacity of normal and skin cancer-affected individuals. D'Errico M; Calcagnile A; Iavarone I; Sera F; Baliva G; Chinni LM; Corona R; Pasquini P; Dogliotti E Cancer Epidemiol Biomarkers Prev; 1999 Jun; 8(6):553-9. PubMed ID: 10385147 [TBL] [Abstract][Full Text] [Related]
10. Benzo[a]pyrene diol epoxide-induced 9p21 aberrations associated with genetic predisposition to bladder cancer. Hazra A; Grossman HB; Zhu Y; Luo S; Spitz MR; Wu X Genes Chromosomes Cancer; 2004 Dec; 41(4):330-8. PubMed ID: 15390186 [TBL] [Abstract][Full Text] [Related]
11. Benzo[a]pyrene diol epoxide-induced 3p21.3 aberrations and genetic predisposition to lung cancer. Wu X; Zhao Y; Honn SE; Tomlinson GE; Minna JD; Hong WK; Spitz MR Cancer Res; 1998 Apr; 58(8):1605-8. PubMed ID: 9563468 [TBL] [Abstract][Full Text] [Related]
12. Chromosome instability in lymphocytes: a potential indicator of predisposition to oral premalignant lesions. Wu X; Lippman SM; Lee JJ; Zhu Y; Wei QV; Thomas M; Hong WK; Spitz MR Cancer Res; 2002 May; 62(10):2813-8. PubMed ID: 12019158 [TBL] [Abstract][Full Text] [Related]
13. Sensitivity to benzo(a)pyrene diol-epoxide associated with risk of breast cancer in young women and modulation by glutathione S-transferase polymorphisms: a case-control study. Xiong P; Bondy ML; Li D; Shen H; Wang LE; Singletary SE; Spitz MR; Wei Q Cancer Res; 2001 Dec; 61(23):8465-9. PubMed ID: 11731429 [TBL] [Abstract][Full Text] [Related]
14. Repair capacity for UV light induced DNA damage associated with risk of nonmelanoma skin cancer and tumor progression. Wang LE; Li C; Strom SS; Goldberg LH; Brewster A; Guo Z; Qiao Y; Clayman GL; Lee JJ; El-Naggar AK; Prieto VG; Duvic M; Lippman SM; Weber RS; Kripke ML; Wei Q Clin Cancer Res; 2007 Nov; 13(21):6532-9. PubMed ID: 17975167 [TBL] [Abstract][Full Text] [Related]
15. Smoking, DNA repair capacity and risk of nonsmall cell lung cancer. Shen H; Spitz MR; Qiao Y; Guo Z; Wang LE; Bosken CH; Amos CI; Wei Q Int J Cancer; 2003 Oct; 107(1):84-8. PubMed ID: 12925960 [TBL] [Abstract][Full Text] [Related]
16. Joint effects of dietary trace metals and DNA repair capacity in lung cancer risk. Mahabir S; Forman MR; Barerra SL; Dong YQ; Spitz MR; Wei Q Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2756-62. PubMed ID: 18086784 [TBL] [Abstract][Full Text] [Related]
17. DNA repair related to multiple skin cancers and drug use. Wei Q; Matanoski GM; Farmer ER; Hedayati MA; Grossman L Cancer Res; 1994 Jan; 54(2):437-40. PubMed ID: 8275480 [TBL] [Abstract][Full Text] [Related]
18. A modified host cell reactivation assay to measure DNA repair capacity for removing 4-aminobiphenyl adducts: a pilot study of bladder cancer. Lin J; Kadlubar FF; Spitz MR; Zhao H; Wu X Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1832-6. PubMed ID: 16030125 [TBL] [Abstract][Full Text] [Related]
19. Removal of benzo(a)pyrene diol epoxide (BPDE)-DNA adducts as a measure of DNA repair capacity in lymphoblastoid cell lines from sisters discordant for breast cancer. Motykiewicz G; Faraglia B; Wang LW; Terry MB; Senie RT; Santella RM Environ Mol Mutagen; 2002; 40(2):93-100. PubMed ID: 12203401 [TBL] [Abstract][Full Text] [Related]
20. A parallel study of in vitro sensitivity to benzo[a]pyrene diol epoxide and bleomycin in lung carcinoma cases and controls. Wu X; Gu J; Amos CI; Jiang H; Hong WK; Spitz MR Cancer; 1998 Sep; 83(6):1118-27. PubMed ID: 9740076 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]